134 related articles for article (PubMed ID: 2314116)
21. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
[TBL] [Abstract][Full Text] [Related]
22. Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Babusíková O; Hrivnáková A; Klobusická M; Mesárosová A; Ujházy P
Neoplasma; 1990; 37(6):693-701. PubMed ID: 2125699
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.
Hoyer JD; Li CY; Yam LT; Hanson CA; Kurtin PJ
Am J Clin Pathol; 1997 Sep; 108(3):308-15. PubMed ID: 9291460
[TBL] [Abstract][Full Text] [Related]
24. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of complete remission in hairy cell leukemia patients treated with alpha-IFN.
Lauria F; Foà R; Raspadori D; Pileri S; Tassinari A; Buzzi M; Zaccaria A; Zinzani PL; Tura S
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():176-8. PubMed ID: 2785426
[TBL] [Abstract][Full Text] [Related]
26. [Immunophenotyping of B lymphoma in bone marrow biopsies. Contribution of 4 monoclonal antibodies used on paraffin-embedded tissues:DDB.42,DNA.7,DNA.44 and DND.53].
Meuge-Moraw C; Bernard MC; Delacretaz F
Ann Pathol; 1993; 13(3):151-6. PubMed ID: 8397539
[TBL] [Abstract][Full Text] [Related]
27. Hairy cell leukemia 1992.
Spielberger RT; Golomb HM
Leukemia; 1992 Nov; 6 Suppl 4():142-6. PubMed ID: 1279327
[TBL] [Abstract][Full Text] [Related]
28. Hairy cell leukemia: current concepts.
Cannon T; Mobarek D; Wegge J; Tabbara IA
Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
[TBL] [Abstract][Full Text] [Related]
29. Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia.
Andrulis M; Penzel R; Weichert W; von Deimling A; Capper D
Am J Surg Pathol; 2012 Dec; 36(12):1796-800. PubMed ID: 22531170
[TBL] [Abstract][Full Text] [Related]
30. Immunohistological analysis of bone marrow involvement in lymphoproliferative disorders. The use of cryostat sections from trephine biopsies.
Pizzolo G; Chilosi M; Fiore-Donati L; Janossy G
Haematologia (Budap); 1984; 17(2):247-57. PubMed ID: 6398792
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibody.
Morgan EA; Yu H; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2013 Feb; 139(2):220-30. PubMed ID: 23355207
[TBL] [Abstract][Full Text] [Related]
32. Minimal residual disease, its detection and significance in hairy-cell leukemia.
Zák P; Chrobák L; Dĕdic K
Acta Medica (Hradec Kralove); 1999; 42(3):85-8. PubMed ID: 10677893
[TBL] [Abstract][Full Text] [Related]
33. Phospho-ERK(THR202/Tyr214) is overexpressed in hairy cell leukemia and is a useful diagnostic marker in bone marrow trephine sections.
Warden DW; Ondrejka S; Lin J; Durkin L; Bodo J; Hsi ED
Am J Surg Pathol; 2013 Feb; 37(2):305-8. PubMed ID: 23211289
[TBL] [Abstract][Full Text] [Related]
34. Current treatment options in hairy cell leukemia and hairy cell leukemia variant.
Robak T
Cancer Treat Rev; 2006 Aug; 32(5):365-76. PubMed ID: 16781083
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
36. Immunogold labelling of leukemic hairy cells with the B-ly7 monoclonal antibody: an SEM and TEM study.
de Harven E; Christensen H; Poppema S; Scott JG
Microsc Res Tech; 1994 Jul; 28(4):356-67. PubMed ID: 7919522
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique.
Vardiman JW; Gilewski TA; Ratain MJ; Bitter MA; Bradlow BA; Golomb HM
Am J Clin Pathol; 1988 Sep; 90(3):250-6. PubMed ID: 2458031
[TBL] [Abstract][Full Text] [Related]
38. Interferon-induced surface alterations in hairy cells. A review.
Gamliel H; Gurfel D; Wu SH; Golomb HM
Scanning Microsc; 1988 Mar; 2(1):485-92. PubMed ID: 3368772
[TBL] [Abstract][Full Text] [Related]
39. The differential diagnosis of hairy cell leukemia with a panel of monoclonal antibodies.
Falini B; Schwarting R; Erber W; Posnett DN; Martelli MF; Grignani F; Zuccaccia M; Gatter KC; Cernetti C; Stein H
Am J Clin Pathol; 1985 Mar; 83(3):289-300. PubMed ID: 3156489
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical evaluation of neoplasms in bone marrow biopsies using monoclonal antibodies reactive in paraffin-embedded tissue.
Kubic VL; Brunning RD
Mod Pathol; 1989 Nov; 2(6):618-29. PubMed ID: 2587569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
